Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
Conditions: Non Small Cell Lung Cancer; Breast Cancer; Colorectal Cancer; Gastric Cancer; Liver Cancer; Advanced Cancer; Immune Checkpoint Inhibitor Sponsors: Gene Solutions Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Colorectal Cancer | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Immunotherapy | Liver | Lung Cancer | Non-Small Cell Lung Cancer | Research | Urology & Nephrology